Order PD-L1 Tissue Assay


Aurora Diagnostics LMC Laboratories is one of the first laboratories to provide the FDA-approved VENTANA PD-L1 (SP142) Assay. The complementary assay is an immunohistochemical tissue assay corresponding with the release of TECENTRIQ™ (atezolizumab).

Aurora Diagnostics LMC Laboratories offers all four FDA approved PD-L1 stains including:
      22C3 for Non-Small Cell Carcinoma (KEYTRUDA)
      28-8 for Melanoma and Non-Small Cell Carcinoma (OPDIVO)
      SP142 for Non-Small Cell Carcinoma and Urothelial Bladder Cancer (TECENTRIQ)
      SP263 for Urothelial Bladder Cancer (DURVALUMAB)

To order the PD-L1 Tissue Assay call 877-LMC-LABS